Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L27a pseudogene 7 (RPL27AP7) is a processed pseudogene in the human genome that shares strong sequence similarity with the functional ribosomal protein L27a gene (RPL27A).[3][4][5][6] Like other pseudogenes, RPL27AP7 does not code for a functional protein and is not known to be translated or involved in canonical ribosomal protein functions. While some ribosomal pseudogenes have been occasionally reported to be transcribed or to play regulatory roles, there is no evidence indicating that RPL27AP7 has such a function[3][4][5]. This locus is not a therapeutic target, nor is it associated with any known drugs, mechanism of action, biomarker utility, or disease role. RPL27AP7 is part of a large family of processed pseudogenes that arose from duplication and retrotransposition events of ribosomal protein genes[1][3][4][5][6]. Its entry in major genetic databases (HGNC, NCBI Gene, Ensembl) consistently describes its status as a pseudogene, with no reported protein product or implication in disease or therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L27a pseudogene 7 (RPL27AP7).